PLA2R1 and membranous glomerulonephritis: According to the guidelines for the diagnosis and treatment of glomerulonephritis issued by KDIGO in 2021, in patients with anti-phospholipase A2 receptor (PLA2R) antibody-positive membranous nephropathy, if the clinical manifestations are typical, kidney biopsy may not be required to confirm the diagnosis [6].